about
Human a-L-fucosidase-1 attenuates the invasive properties of thyroid cancer.Marine Lectins DlFBL and HddSBL Fused with Soluble Coxsackie-Adenovirus Receptor Facilitate Adenovirus Infection in Cancer Cells BUT Have Different Effects on Cell SurvivalPlant Lectins as Medical Tools against Digestive System Cancers.The Glycosyltransferase ST6Gal-I Protects Tumor Cells against Serum Growth Factor Withdrawal by Enhancing Survival Signaling and Proliferative Potential.Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell ViabilityE-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271.Harnessing Solute Carrier Transporters for Precision Oncology.Epigenetic Regulation of the Biosynthesis & Enzymatic Modification of Heparan Sulfate Proteoglycans: Implications for Tumorigenesis and Cancer Biomarkers.Global and targeted serum metabolic profiling of colorectal cancer progression.Structural basis for dolichylphosphate mannose biosynthesis.Neutrophil-to-Lymphocyte Ratio Is a Potential Prognostic Biomarker in Patients with Ovarian Cancer: A Meta-Analysis.Three-Dimensionally Functionalized Reverse Phase Glycoprotein Array for Cancer Biomarker Discovery and Validation.sp2 -Iminosugar α-glucosidase inhibitor 1-C-octyl-2-oxa-3-oxocastanospermine specifically affected breast cancer cell migration through Stim1, β1-integrin, and FAK signaling pathways.Reprogramming of leukemic cell metabolism through the naphthoquinonic compound Quambalarine B.miR-182 and miR-135b Mediate the Tumorigenesis and Invasiveness of Colorectal Cancer Cells via Targeting ST6GALNAC2 and PI3K/AKT Pathway.The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr-1-mediated regulation.Gaining insights into cancer biology through exploration of the cancer secretome using proteomic and bioinformatic tools.Targeting cancer-specific glycans by cyclic peptide lectinomimics.Reduced mannosidase MAN1A1 expression leads to aberrant N-glycosylation and impaired survival in breast cancer.Computer-aided design of human sialyltransferase inhibitors of hST8Sia III.Hyperglycemia and aberrant O-GlcNAcylation: contributions to tumor progression.The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1α signaling.The role of epithelial cell adhesion molecule N-glycosylation on apoptosis in breast cancer cells.Prognostic value of platelet-to-lymphocyte ratio in pancreatic cancer: a comprehensive meta-analysis of 17 cohort studies.Fucosylated Antigens in Cancer: An Alliance toward Tumor Progression, Metastasis, and Resistance to Chemotherapy.Use of CA15‑3 for screening breast cancer: An antibody‑lectin sandwich assay for detecting glycosylation of CA15‑3 in sera.Loss and gain of N-linked glycosylation sequons due to single-nucleotide variation in cancer.DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling.Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring.Enhanced motility and proliferation by miR-10b/FUT8/p-AKT axis in breast cancer cells.Glycogene expression profiles based on microarray data from cervical carcinoma HeLa cells with partially silenced E6 and E7 HPV oncogenesDistinct urinary glycoprotein signatures in prostate cancer patients
P2860
Q33688938-1763E8CD-DDFF-4C10-9E3D-504519CB051FQ37721826-CE31E8A3-48AE-4929-A951-365AF943CB7AQ38696887-E3E84352-02CB-4769-BAE8-2E1C0013987CQ38718209-AB57E10F-96D4-41B5-8022-87895C5DBE1CQ38757500-EB1ADC81-D79E-4913-91C3-A68B85EA878CQ38821948-AA6AE387-3914-406B-B5EA-8DCC21590FBEQ39204754-A0F5CA59-C368-493A-9016-538CBCAD2FDFQ39411671-C5365851-6C89-445C-AD3A-3A34F6B2C2C0Q40149592-6FEDB612-D96F-4201-BB6E-C9DEA796B523Q41124753-7F003D9A-3196-46BA-B8F8-EB95F75D6F26Q41320252-0A7A4AA8-7559-4725-A70D-9C15A40F8A68Q44452599-5CBF1A6C-78AC-4659-8E87-F8EA9E6CC207Q46719191-A097F988-0C60-4A38-80C6-440FA5BA0F62Q47164149-BBE25B46-490D-4385-B253-DD6E4C166427Q47654640-F42E5A1C-2FD4-4A29-8761-23392E999627Q47678239-7975C729-5264-4207-BD41-97E6C5619DD1Q47716837-D40227E0-FDE1-46B2-B9EB-A91E33FA0117Q47819361-64395038-6792-44AC-9767-F6141E1A2768Q47831739-9895172D-525B-425C-BEA7-A4C0C8F21BDEQ48336629-D6989514-819E-497E-A178-A9E9C01FBC49Q50098159-4CA021CC-BA53-479F-BFE3-23E168F3C7ABQ50422095-3EE5FC8D-9CE1-47E1-A4D1-FB073BAEF211Q51083068-AC9E364F-190B-4B0D-AFB8-2EBEA110173EQ52579384-AAD6E7C2-885E-447E-BC15-1DB04A4B0DC4Q53703015-20BCCA81-F1C1-4E09-B2E0-AAD3D08A7606Q54214732-7EF831B3-7751-47E4-9191-3A09AF01D0D1Q55053200-AD354CF5-4936-40DE-8EF0-0AC6DC582450Q55223367-D2C93B18-E6F4-417D-BECF-4D7CFA6ADB83Q55424250-E720D566-49C1-4AE6-85D0-DFD0420810FFQ55497180-7CF9C828-8F8D-48D7-980F-93E3FE8D8C7BQ55709884-F8F8F224-FE8C-46C5-A9C7-05A7B2572CF4Q56889497-BD054A33-43B0-47FC-84EB-2902998CE9A8Q58764443-581999CD-ED0B-4C05-91B4-93B7BEB16001
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Hallmarks of glycosylation in cancer
@ast
Hallmarks of glycosylation in cancer
@en
Hallmarks of glycosylation in cancer
@nl
type
label
Hallmarks of glycosylation in cancer
@ast
Hallmarks of glycosylation in cancer
@en
Hallmarks of glycosylation in cancer
@nl
prefLabel
Hallmarks of glycosylation in cancer
@ast
Hallmarks of glycosylation in cancer
@en
Hallmarks of glycosylation in cancer
@nl
P2860
P3181
P356
P1433
P1476
Hallmarks of glycosylation in cancer
@en
P2093
David J Elliott
Jennifer Munkley
P2860
P304
35478-35489
P3181
P356
10.18632/ONCOTARGET.8155
P407
P5008
P577
2016-06-01T00:00:00Z